Genetic immunization for Chlamydia psittaci

Area of Science:

• Veterinary Immunology
• Molecular Biology
• Infectious Diseases

Background:

• Chlamydia psittaci poses a significant threat to avian health, causing respiratory and systemic infections.
• The major outer membrane protein (MOMP) is a key target for immune responses against Chlamydia species.
• Developing effective vaccination strategies against Chlamydia psittaci is crucial for poultry industry biosecurity.

Purpose of the Study:

• To evaluate the immunogenicity and protective efficacy of plasmid DNA encoding Chlamydia psittaci MOMP in a turkey model.
• To compare different DNA delivery methods, including parenteral-mucosal and gene gun immunization.
• To assess the induction of both humoral and cellular immune responses following vaccination.

Main Methods:

• Plasmid DNA encoding MOMP from an avian Chlamydia psittaci serovar A strain was constructed.
• Immunization was performed using intramuscular-intranasal delivery or gene gun delivery of the DNA vaccine.
• Immune responses were assessed by measuring antibody isotypes (IgG, IgM) and lymphocyte proliferation.
• Protection was evaluated by challenging vaccinated turkeys and monitoring clinical signs, lesions, and chlamydia excretion.

Main Results:

• Both immunization methods induced T-helper and B-cell memory, evidenced by IgG antibody production and heightened lymphocyte proliferation.
• While antibody responses were not consistently high, significant T-cell memory was observed in all vaccinated turkeys.
• All turkeys vaccinated with MOMP DNA showed a significant level of protection against Chlamydia psittaci challenge.
• Vaccination effectively reduced severe clinical signs, lesions, and chlamydia shedding.

Conclusions:

• MOMP-based DNA vaccination is a promising strategy for inducing protective immunity against Chlamydia psittaci infection in turkeys.
• The vaccine effectively primes cellular immunity, leading to significant protection despite variable antibody titers.
• This approach demonstrates the potential for controlling Chlamydia psittaci in poultry through targeted DNA vaccination.